<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D9ADB7CE-BD2F-404E-8756-75793E622671"><gtr:id>D9ADB7CE-BD2F-404E-8756-75793E622671</gtr:id><gtr:firstName>Babak</gtr:firstName><gtr:surname>Javid</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601934"><gtr:id>D16C6817-7AA0-45A7-B96C-CD8E0BA0D8E5</gtr:id><gtr:title>Immunoevasion mechanisms by Mycobacterium tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601934</gtr:grantReference><gtr:abstractText>Tuberculosis affects 2 billion people worldwide. The bacteria causing TB, Mycobacterium tuberculosis can lie dormant within an infected host for decades in a chronic state. In order to survive within the host, TB evolved means to evade the immune response of the human host. Immune responses are initiated by specialised cells, known as antigen presenting cells (APC). The aim of this project will be to identify and characterise the TB-derived factors that help TB evade detection by the arm of the immune response that employs T lymphocytes. A TB strain will be genetically modified to express a protein, ovalbumin. There are many useful immunological tools that can be used to precisely quantify immune responses against ovalbumin, as a surrogate for immunity to the TB itself. A library of mutant strains of these bacteria, with all non-essential genes knocked out, will be generated. Two screens will be employed to identify which genes are responsible for down-regulation of T lymphocyte responses against TB: using APC in cell culture, and also using live mice. The candidate genes identified with the screens will have their functions characterised using biochemical methods. Through better understanding how TB subverts immunity, better vaccines and therapeutic targets can be developed.</gtr:abstractText><gtr:technicalSummary>Tuberculosis is a major global health crisis. Despite widespread use of the bacillus Calmette-Guerin (BCG) vaccine and availability of effective drug therapy, Mycobacterium tuberculosis (Mtb) remains the most common causes of infectious disease morbidity worldwide. Like other pathogens that establish a state of chronic, controlled infection, M. tuberculosis has evolved mechanisms to evade the host immune response. These immune responses are initiated by professional antigen presenting cells (APC), such as dendritic cells (DC). The objectives of this project are to determine: (i) What mycobacterial genetic factors are necessary for access of M. tuberculosis to the antigen loading machinery of APC, and (ii) how mycobacteria evade the adaptive immune response. I will make a transgenic strain of M. tuberculosis expressing ovalbumin and a high density random insertion mutant library of this strain will be constructed. The mutant library will be used in an in vivo screen using wild-type and ova-immunised mice. Decreased survival of mycobacteria in the immunised mice will imply those strains also have defects in immunoevasion. These mutants will be identified using a novel screen - transposon site hybridisation (TraSH). A quantitative in vitro antigen presentation assay will also be set-up using primary murine DC and macrophages; and OVA-peptide specific hybridoma cell-lines and the clonotypic antibody 25.D1.16. The mutant TB library will be tested using this assay to identify strains that exhibit enhanced antigen presentation, implying a defect in immunoevasion. The functions of the identified candidate gene products will be characterised by biochemical and cell-biological means.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>744534</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Biology Society talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6878776D-57A9-461B-B068-89D7C722EDFE</gtr:id><gtr:impact>Invited keynote speaker at Biology Honors Society at Simmons college -- audience composed of c. 60 students/parents/faculty. There were a lot of questions and discussion as a result of the talk.

Have offered to mentor students interested in global health, and been in contact with faculty members post event.</gtr:impact><gtr:outcomeId>SAyg3qr5d7x</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Understanding Science' talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>23417D63-4F86-4B84-9CB3-3C947B416B32</gtr:id><gtr:impact>50 members of public attended this talk as part of an ongoing series about science communication to the public from professional researchers in Beijing.

The talk resulted in a final year high school student coming to my lab for a one month internship, and a subsequent career choice change to study biomedical sciences at a UK university.</gtr:impact><gtr:outcomeId>deg58mKXu5e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Tsinghua Public Health Day&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BECD82E0-A675-4ED2-B952-F115991C4BA0</gtr:id><gtr:impact>A talk as part of a Tsinghua University Public Health day on the theme of Tuberculosis. attended by media, members of the public and health professionals. Also involved a 30 minute press conference following the event with 5 members of the National Chinese Press.

Increased Chinese public awareness about tuberculosis, and hopefully, diminished stigma associated with the condition.</gtr:impact><gtr:outcomeId>HvroidHfyu5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F847AEF8-2F09-4109-9519-CFA11DBC5009</gtr:id><gtr:impact>Radio interview on Iranian satellite radio station: &amp;quot;Payam-e Doost&amp;quot;. Was interviewed on their regular medicine/science slot. Interview also included general discussion surrounding TB.

Increased general awareness about TB and TB-related research to target audience</gtr:impact><gtr:outcomeId>3BF6E9507C3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Grand Challenges Explorations</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>3F107C8E-DE07-47AF-8C84-98076AFD52C1</gtr:id><gtr:outcomeId>ZwCKGoYRxmt</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Gates Scholars for Keystone symposia</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Keystone Symposia on Molecular and Cellular Biology</gtr:fundingOrg><gtr:id>57976915-D16D-4476-AACD-0F755C60FB78</gtr:id><gtr:outcomeId>HFA2A7DWvJt0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Grand Challenges Explorations</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>20274EC9-42FD-4C70-8979-D070CE676B13</gtr:id><gtr:outcomeId>AuuzrXBdrkC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Meeting with EC members on European Researcher mobility</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9E65504F-7E93-40E0-9274-2E85CECFE045</gtr:id><gtr:outcomeId>ZwgTjfZdf6w</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>54BF88D9-0022-4433-B0B8-D82705D3C3DC</gtr:id><gtr:title>Structure and function: heat shock proteins and adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/903c094a6c5f308416c2cb40d69b5716"><gtr:id>903c094a6c5f308416c2cb40d69b5716</gtr:id><gtr:otherNames>Javid B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d4eb687b415.33222253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0801D09B-527C-4C92-8A92-156BCA7E5303</gtr:id><gtr:title>Human H+ATPase a4 subunit mutations causing renal tubular acidosis reveal a role for interaction with phosphofructokinase-1.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee81ca88ba433a56fb873f9d3d1ae425"><gtr:id>ee81ca88ba433a56fb873f9d3d1ae425</gtr:id><gtr:otherNames>Su Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>E05DBE2D6E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00B2380A-362A-49B3-BB3E-FE6817CD600D</gtr:id><gtr:title>Functional role of methylation of G518 of the 16S rRNA 530 loop by GidB in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06660a72ec1d8b3eeaf7393939427d1f"><gtr:id>06660a72ec1d8b3eeaf7393939427d1f</gtr:id><gtr:otherNames>Wong SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>pm_16338_28_24100503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1113489-FFB1-4D7E-AFB9-97B8A21FFB84</gtr:id><gtr:title>Schistosomal colonic polyposis in an HIV-positive man.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/903c094a6c5f308416c2cb40d69b5716"><gtr:id>903c094a6c5f308416c2cb40d69b5716</gtr:id><gtr:otherNames>Javid B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>E436E0018B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>415B1A94-93D4-49BC-8DC5-A1C81206876A</gtr:id><gtr:title>A 58-year-old woman with abdominal symptoms and elevated C-reactive protein.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93b31ed653407a8c19a91c24d47860ce"><gtr:id>93b31ed653407a8c19a91c24d47860ce</gtr:id><gtr:otherNames>Daly ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>1D9AC52A9A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBF247FF-1F08-49FD-B842-D9F139DF969B</gtr:id><gtr:title>MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe4480b3e2f6dbdefb421eaaded2ea5c"><gtr:id>fe4480b3e2f6dbdefb421eaaded2ea5c</gtr:id><gtr:otherNames>La Rosa V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>YibEHTXRXr4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E8ADBE7-AD86-4A3B-A301-6825AE89F2FD</gtr:id><gtr:title>Nanotubes: shaking hands, talking, or sharing?</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/903c094a6c5f308416c2cb40d69b5716"><gtr:id>903c094a6c5f308416c2cb40d69b5716</gtr:id><gtr:otherNames>Javid B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>pm_16338_28_21833333</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601934</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>